Cargando…
LASSBio-1586, an N-acylhydrazone derivative, attenuates nociceptive behavior and the inflammatory response in mice
Pain and inflammation are complex clinical conditions that are present in a wide variety of disorders. Most drugs used to treat pain and inflammation have potential side effects, which makes it necessary to search for new sources of bioactive molecules. In this paper, we describe the ability of LASS...
Autores principales: | Silva, Juliane Cabral, de Oliveira Júnior, Raimundo Gonçalves, Silva, Mariana Gama e, de Lavor, Érica Martins, Soares, Juliana Mikaelly Dias, de Lima-Saraiva, Sarah Raquel Gomes, Diniz, Tâmara Coimbra, Mendes, Rosemairy Luciane, de Alencar Filho, Edilson Beserra, Barreiro, Eliezer Jesus de Lacerda, Lima, Lídia Moreira, Almeida, Jackson Roberto Guedes da Silva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6066216/ https://www.ncbi.nlm.nih.gov/pubmed/30059558 http://dx.doi.org/10.1371/journal.pone.0199009 |
Ejemplares similares
-
Discovery of Putative Dual Inhibitor of Tubulin and EGFR by Phenotypic Approach on LASSBio-1586 Homologs
por: Barbosa, Gisele, et al.
Publicado: (2022) -
Impairment of locomotor activity induced by the novel
N-acylhydrazone derivatives LASSBio-785 and LASSBio-786 in
mice
por: Silva, G.A.P., et al.
Publicado: (2013) -
Design and Synthesis In Silico Drug-like Prediction and Pharmacological Evaluation of Cyclopolymethylenic Homologous of LASSBio-1514
por: Lima, Lidia Moreira, et al.
Publicado: (2021) -
Pre-clinical evaluation of LASSBio-1491: From in vitro pharmacokinetic study to in vivo leishmanicidal activity
por: de Queiroz, Aline Cavalcanti, et al.
Publicado: (2022) -
In Vitro, In Vivo and In Silico Effectiveness of LASSBio-1386, an N-Acyl Hydrazone Derivative Phosphodiesterase-4 Inhibitor, Against Leishmania amazonensis
por: Silva, Dahara Keyse Carvalho, et al.
Publicado: (2020)